BLIS Technologies (BLIS Technologies) Issuance of Debt : $0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is BLIS Technologies Issuance of Debt?

BLIS Technologies's Issuance of Debt for the six months ended in Sep. 2023 was $0.00 Mil.

BLIS Technologies's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.

BLIS Technologies Issuance of Debt Historical Data

The historical data trend for BLIS Technologies's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies Issuance of Debt Chart

BLIS Technologies Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Issuance of Debt

Get a 7-Day Free Trial

0.40

BLIS Technologies Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Issuance of Debt	Get a 7-Day Free Trial															-	-	-	-	-

BLIS Technologies Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

BLIS Technologies Issuance of Debt Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BLIS Technologies (BLIS Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (OTCPK:BLTHF) » Definitions » Issuance of Debt

Comparable Companies

Traded in Other Exchanges

BLT:New Zealand

Address

442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016

Website

https://www.blis.co.nz

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).

BLIS Technologies (BLIS Technologies) Headlines

No Headlines